Your browser doesn't support javascript.
loading
Developing a Process for Returning Medically Actionable Genomic Variants to Latino Patients in a Federally Qualified Health Center.
Shaibi, Gabriel Q; Kullo, Iftikhar J; Singh, Davinder P; Sharp, Richard R; De Filippis, Eleanna; Cuellar, Idali; Hernandez, Valentina; Levey, Sharon; Radecki Breitkopf, Carmen; Olson, Janet E; Cerhan, James R; Mandarino, Lawrence J; Thibodeau, Stephen N; Lindor, Noralane M.
Afiliação
  • Shaibi GQ; Center for Health Promotion and Disease Prevention, College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA, gshaibi@asu.edu.
  • Kullo IJ; Department of Cardiovascular Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Singh DP; Mountain Park Health Center, Phoenix, Arizona, USA.
  • Sharp RR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • De Filippis E; Department of Endocrinology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Cuellar I; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Hernandez V; Mountain Park Health Center, Phoenix, Arizona, USA.
  • Levey S; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Radecki Breitkopf C; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Cerhan JR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Mandarino LJ; Division of Endocrinology, Department of Medicine, and Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, Arizona, USA.
  • Thibodeau SN; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Lindor NM; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Public Health Genomics ; 21(1-2): 77-84, 2018.
Article em En | MEDLINE | ID: mdl-30522109
ABSTRACT

AIM:

To develop a process for returning medically actionable genomic variants to Latino patients receiving care in a Federally Qualified Health Center.

METHODS:

Prior to recruitment, researchers met with primary care providers to (1) orient clinicians to the project, (2) establish a process for returning actionable and nonactionable results to participants and providers through the electronic health record, and (3) develop a process for offering clinical decision support for follow-up education and care. A Community Advisory Board was engaged to provide input on recruitment strategies and materials for conveying results to participants. Participants in the Sangre Por Salud (Blood for Health) Biobank with hyperlipidemia or colon polyps represented the pool of potentially eligible participants.

RESULTS:

A total of 1,621 individuals were invited to participate and 710 agreed to an in- person consenting visit (194 no-showed and 16 declined). Over 12-months, 500 participants were enrolled. Participants were primarily Spanish-speaking (81.6%), female (74.2%), and enrolled because of hyperlipidemia (95.4%). All but 2 participants opted to receive primary (i.e., related to enrollment phenotypes) as well as secondary actionable results.

CONCLUSION:

Efforts to bring precision medicine to community-based health centers serving minority patients may require multilevel engagement activities to include individuals, providers, health systems, and the community.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hispânico ou Latino / Bancos de Espécimes Biológicos / Centros Comunitários de Saúde / Genômica Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hispânico ou Latino / Bancos de Espécimes Biológicos / Centros Comunitários de Saúde / Genômica Idioma: En Ano de publicação: 2018 Tipo de documento: Article